comparemela.com

Latest Breaking News On - Directed agents - Page 1 : comparemela.com

Efficacy With NRG1-Directed Agents in NSCLC

D. Ross Camidge, MD, PhD, of University of Colorado Health Lung Cancer Clinic – Anschutz Medical Campus, discusses clinical efficacy with agents targeted for NRG1-fusion–positive non–small cell lung cancer.

HER2-Directed Agents in NSCLC

Dr Wade Thomas Iams explains how trastuzumab deruxtecan became the standard-of-care for HER2-mutated non-small cell lung cancer.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.